American CryoStem Corporation
CRYO · OTC
9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 0.00 | 0.49 | 0.00 |
| FCF Yield | -2.18% | -2.80% | -3.11% | -1.27% |
| EV / EBITDA | -7.18 | -37.93 | -20.47 | -26.60 |
| Quality | ||||
| ROIC | -817.61% | -46.33% | -143.58% | -173.06% |
| Gross Margin | 34.08% | 92.14% | 90.09% | 73.08% |
| Cash Conversion Ratio | 0.11 | 0.44 | 0.46 | 0.12 |
| Growth | ||||
| Revenue 3-Year CAGR | -60.00% | -20.33% | -44.34% | 22.93% |
| Free Cash Flow Growth | 25.05% | 3.56% | -36.90% | -253.65% |
| Safety | ||||
| Net Debt / EBITDA | -0.43 | -1.75 | -1.08 | -0.58 |
| Interest Coverage | -21.24 | -1.94 | -7.31 | -12.74 |
| Efficiency | ||||
| Inventory Turnover | 0.76 | 2.15 | 1.23 | 8.81 |
| Cash Conversion Cycle | -12,995.45 | -1,017.77 | -3,013.39 | -468.82 |